BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 8736325)

  • 1. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM; Crowson AN; Harrist TJ
    Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus.
    Magro CM; Crowson AN
    J Cutan Pathol; 1997 Oct; 24(9):543-52. PubMed ID: 9404851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
    Magro CM; Dyrsen ME
    J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
    Tebbe B; Orfanos CE
    Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
    Böckle BC; Stanarevic G; Sepp NT
    J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of lupus erythematosus based upon Japanese patients.
    Tsuchida T
    Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects and differential diagnosis of cutaneous lupus erythematosus].
    Kind P; Goerz G
    Z Hautkr; 1987 Sep; 62(18):1337-8, 1341-2, 1347. PubMed ID: 3687157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing subacute cutaneous from other types of lupus erythematosus.
    McCauliffe DP
    Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosis.
    Schiødt M; Permin H; Wiik A; Manthorpe R
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):59-63. PubMed ID: 6603096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic lupus erythematosus, subacute cutaneous lupus].
    Doutre MS; Beylot C
    Rev Prat; 1990 Sep; 40(21):1930-4. PubMed ID: 2237183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.